SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-17-000005
Filing Date
2017-01-12
Accepted
2017-01-11 21:54:19
Documents
1
Period of Report
2017-01-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rvnc8k1617.htm 8-K 24470
  Complete submission text file 0001479290-17-000005.txt   25469
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 17523862
SIC: 2834 Pharmaceutical Preparations